Maximal Medical Treatment of Intracerebral Haemorrhage Pilot Trial - MAX-ICH Pilot Trial

Inclusion Criteria: * Symptomatic imaging proven diagnosis of non-traumatic ICH * Vascular imaging (MR-/CT-angiogram or DSA) on admission to rule out high suspicion of macrovascular bleeding source * Enrolment no later than 6 hours of symptom onset * Age \>18 years, no upper age limit * Informed consent as documented by signature or fulfilling the criteria for emergency consent/ deferral consent Exclusion Criteria: * Palliative care/comfort therapy decision in the emergency department * ICH due to trauma (major head trauma \<24 hours of symptom onset causing loss of consciousness and thought to be sufficient to have caused the intracerebral bleeding) * High suspicion of ICH due to arteriovenous malformation (AVM), aneurysm or sinus-venous-thrombosis confirmed by neuroimaging, brain tumor, vasculitis, RCVS/PRES or system disease (liver disease, inherit coagulopathy) * Severe ICH (haematoma volume \>60ml or GCS \<8) * Haematoma evacuation or decompressive craniectomy within 72 hours planned or highly likely (isolated EVD is not an exclusion criterion) * Severe pre-morbid disability \[modified Rankin scale (mRS) is ≥4\] * Contraindication against the use of tranexamic acid * Active participation in another drug or devices trial concurrently * Female patient that are either pregnant or breastfeeding * Contraindications against Clevidipine (allergy to soja, lipid metabolism defect or known severe aortic stenosis)